Sensora (Mouth/Throat) (15 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Invision Medi Sciences. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Choline Salicylate, Lignocaine Hydrochloride IP. This drug comes in the form of Gel. The general packing available for this medicine consists of 15 gm and is priced at Rs 35 (arround $0.49 US Dollar)
Choline Salicylate Indication (Prescribed for or used as): Choline salicylate along with magnesium salicylate is used to relieve pain in various conditions. It also reduces pain, swelling and joint stiffness in arthritis.
For more details on Choline Salicylate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Choline Salicylate..
Lignocaine Hydrochloride IP Indication (Prescribed for or used as):
For more details on Lignocaine Hydrochloride IP, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Lignocaine Hydrochloride IP..
Sensora (Mouth/Throat) (15 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Sensora (Mouth/Throat) (15 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Choline Salicylate-8.7% w/w Lignocaine Hydrochloride IP-2% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.